From Advocacy to Access: Mito Community Celebrates FDA Milestone
Barth syndrome therapy sets precedent for future treatments targeting mitochondrial dysfunction In a landmark decision, the U.S. Food and Drug […]
Barth syndrome
Barth syndrome therapy sets precedent for future treatments targeting mitochondrial dysfunction In a landmark decision, the U.S. Food and Drug […]